![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C. $135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.](https://www.lawmbg.com/wp-content/uploads/2019/01/iStock-Pills.jpg)
$135 Million Settlement in Illinois AWP Litigation Against Teva Pharmaceuticals USA, Inc. | Miner, Barnhill & Galland, P.C.
![New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel](https://static.timesofisrael.com/www/uploads/2018/07/teva.jpg)
New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel
Teva Pharmaceuticals USA - As the world's largest manufacturer of quality generic medicines, we're proud to produce many of the drugs on the WHO's Essential Medicines List. Find out more here: https://bit.ly/3Au4h3X #
![Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal](https://media.bizj.us/view/img/10278469/unknown-6*1200xx2016-1136-0-122.jpg)
Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal
![Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates, Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,](https://c8.alamy.com/comp/2CX4Y3N/teva-pharmaceutical-industries-new-ceo-jeremy-levin-speaks-during-a-news-conference-in-tel-aviv-may-9-2012-teva-pharmaceutical-industries-posted-a-40-percent-jump-in-quarterly-profit-that-beat-estimates-boosted-by-robust-sales-of-its-own-branded-products-and-generic-medicines-in-the-united-states-reutersnir-elias-israel-tags-business-health-2CX4Y3N.jpg)